Document:

Form of Note for the Company's Floating Rate Notes due April 27, 2018

 Exhibit 4.01 

This Note is a Global Security within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository
named below or a nominee of the Depository. This Note is not exchangeable for Notes registered in the name of a Person other than the Depository or its nominee except in the limited circumstances described herein and in the Indenture, and no
transfer of this Note (other than a transfer of this Note as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository) may be registered except in the limited
circumstances described herein. 
 Unless this certificate is presented by an authorized representative of The Depository Trust Company, a
New York corporation (the “Depository”), to the Company or its agent for registration of transfer, exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by
an authorized representative of the Depository (and any payment is made to Cede & Co. or to such other entity as is requested by an authorized representative of the Depository), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest herein. 

CITIGROUP INC. 
 Floating
Rate Notes due April 27, 2018 
  

			
	REGISTERED		REGISTERED
		
			CUSIP: 172967JQ5
			ISIN: US172967JQ58
			Common Code: 122574890
		
	No. R-001		$500,000,000

 CITIGROUP INC., a Delaware corporation (the “Company”, which term includes any successor Person
under the Indenture), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of $500,000,000 on April 27, 2018 and to pay interest thereon from and including April 27, 2015 or from the
most recent Interest Payment Date to which interest has been paid or duly provided for, quarterly, on the twenty-seventh day of each January, April, July, and October, commencing July 27, 2015, at the rate per annum for each Interest Period of
three-month LIBOR, determined as provided herein, plus 0.6900% until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in the
Indenture, be paid to the Person in whose name this Note is registered at the close of business on the Record Date for such interest, which shall be the Business Day immediately preceding such Interest Payment Date. 

Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the holder on such Record Date and may
either be paid to the Person in whose name this Note is registered at the close of business on a subsequent Record Date, such subsequent Record Date to be not less than ten days prior to the date of payment of such defaulted interest, notice whereof
shall be given to holders of Notes of this series not less than ten days prior to such subsequent Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Notes of
this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in the Indenture. 

 Interest hereon will be calculated on the basis of the actual number of days elapsed in an
Interest Period and a 360-day year. Dollar amounts resulting from such calculation will be rounded to the nearest cent, with one-half cent being rounded upward. An “Interest Period” shall be the period from and including an Interest
Payment Date (or from April 27, 2015 in the case of the first Interest Payment Date) to and including the day immediately preceding the next Interest Payment Date. 

If an Interest Payment Date falls on a day that is not a Business Day, such Interest Payment Date will be the next succeeding Business Day. If
the Maturity of the Notes falls on a day that is not a Business Day, the payment due on Maturity will be postponed to the next succeeding Business Day, and no further interest will accrue in respect of such postponement. If a date for payment of
interest or principal on the Notes falls on a day that is not a business day in the place of payment, such payment will be made on the next succeeding business day in such place of payment as if made on the date the payment was due. No interest will
accrue on any amounts payable for the period from and after the due date for payment of such principal or interest. 
 For these purposes,
“Business Day” means any day which is a day on which commercial banks settle payments and are open for general business in The City of New York. 

Payment of the principal of and interest on this Note will be made at the office or agency of the Trustee maintained for that purpose in The
City of New York. 
 Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further
provisions shall for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has
been executed by the Trustee or by an authenticating agent on behalf of the Trustee by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 2 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its
corporate seal. 
 Dated: April 27, 2015 
  

			
	CITIGROUP INC.
		
	By:		  

	Name:		
	Title:		

  

			
	ATTEST:
		
	By:		  

	Name:		
	Title:		Assistant Secretary

  
 3 

 This is one of the Notes of the series issued under the within-mentioned Indenture. 

Dated: April 27, 2015 
  

			
	THE BANK OF NEW YORK MELLON,
	as Trustee
		
	By:		  

	Name:		
	Title:		
	
	-or-
	
	CITIBANK, N.A.,
	as Authenticating Agent
		
	By:		  

	Name:		
	Title:		

  
 4 

 This Note is one of a duly authorized issue of Securities of the Company (the “Notes”),
issued and to be issued in one or more series under the Indenture, dated as of November 13, 2013 (as amended and supplemented from time to time, the “Indenture”), between the Company and The Bank of New York Mellon, as Trustee (the
“Trustee”, which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and
immunities thereunder of the Company, the Trustee and the holders of the Notes and of the terms upon which the Notes are, and are to be, authenticated and delivered. This Note is one of the series designated on the face hereof, initially limited in
aggregate principal to $1,000,000,000. 
 This Note will bear interest for each Interest Period at a rate determined by Citibank, N.A.,
acting as Calculation Agent. The interest rate on this Note for a particular Interest Period will be a per annum rate equal to three-month LIBOR as determined on the related Interest Determination Date, plus 0.6900%. The Interest Determination Date
for an Interest Period will be the second London business day preceding such Interest Period. The Interest Determination Date for the first Interest Period was April 23, 2015. Promptly upon determination, the Calculation Agent will inform the
Trustee and the Company of the interest rate for the next Interest Period. Absent manifest error, the determination of the interest rate by the Calculation Agent shall be binding and conclusive on the holders of Notes, the Trustee and the Company.

 A London business day is a day on which dealings in deposits in U.S. dollars are transacted in the London interbank market. 

On any Interest Determination Date, LIBOR will be equal to the offered rate for deposits in U.S. dollars having an index maturity of three
months for the next Interest Period, in amounts of at least $1,000,000, as such rate appears on Reuters Screen LIBOR01 at approximately 11:00 a.m., London time, on such Interest Determination Date. If the Reuters Screen LIBOR01 is replaced by
another service or ceases to exist, the Calculation Agent will use the replacing service or such other service that is selected to display the London interbank offered rates for U.S. dollar deposits. 

If no offered rate appears on Reuters Screen LIBOR01 on an Interest Determination Date at approximately 11:00 a.m., London time, then the
Calculation Agent (after consultation with the Company) will select four major banks in the London interbank market and shall request each of their principal London offices to provide a quotation of the rate at which three-month deposits in U.S.
dollars in amounts of at least $1,000,000 are offered by it to prime banks in the London interbank market, on that date and at that time, that is representative of single transactions at that time. If at least two quotations are provided, LIBOR will
be the arithmetic average of the quotations provided. Otherwise, the Calculation Agent will select three major banks in New York City and shall request each of them to provide a quotation of the rate offered by them at approximately 11:00 a.m., New
York City time, on the Interest Determination Date for loans in U.S. dollars to leading European banks having an index maturity of three months for the applicable Interest Period in an amount of at least $1,000,000 that is representative of single
transactions at that time. If three quotations are provided, LIBOR will be the arithmetic average of the quotations provided. Otherwise, the rate of LIBOR for the next Interest Period will be set equal to the rate of LIBOR for the current Interest
Period. 

  
 5 

 Upon request from any Noteholder, the Calculation Agent will provide the interest rate in effect
on this Note for the current Interest Period and, if it has been determined, the interest rate to be in effect for the next Interest Period. 

If an event of default (as defined in the Indenture) with respect to Notes of this series shall occur and be continuing, the principal of the
Notes of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 
 Sections 12.02 and
12.03 of the Indenture containing provisions for defeasance apply to this Note. At any time the entire indebtedness of this Note may be defeased upon compliance by the Company with certain conditions set forth in Section 12.04 of the Indenture.

 The Indenture contains provisions permitting the Company and the Trustee, without the consent of the holders of the Securities, to
establish, among other things, the form and terms of any series of Securities issuable thereunder by one or more supplemental indentures, and, with the consent of the holders of a majority in aggregate principal amount of Securities at the time
outstanding which are affected thereby, to modify the Indenture or any supplemental indenture or the rights of the holders of Securities of such series to be affected, provided that no such modification will (i) extend the fixed maturity of any
Securities, reduce the rate or extend the time of payment of interest thereon, reduce the principal amount thereof or the premium, if any, thereon, reduce the amount of the principal of Original Issue Discount Securities payable on any date, change
the currency in which Securities are payable, or impair the right to institute suit for the enforcement of any such payment on or after the maturity thereof, without the consent of the holder of each Security so affected, or (ii) reduce the
aforesaid percentage of Securities of any series the consent of the holders of which is required for any such modification without the consent of the holders of all Securities of such series then outstanding, or (iii) modify the rights, duties
or immunities of the Trustee unless the Trustee agrees to such modification. 
 No reference herein to the Indenture and no provision of
this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Note at the times, place and rate, and in the coin or currency, herein prescribed.

 This Note is a Global Security registered in the name of a nominee of the Depository. This Note is exchangeable for Notes registered in
the name of a person other than the Depository or its nominee only in the limited circumstances hereinafter described. Unless and until it is exchanged in whole or in part for definitive Notes in certificated form, this Note may not be transferred
except as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository. 

The Notes represented by this Global Security are exchangeable for definitive Notes in certificated form of like tenor as such Notes in
denominations of $1,000 and whole multiples of 

  
 6 

 
$1,000 in excess thereof only if (i) the Depository notifies the Company that it is unwilling or unable to continue as Depository for the Notes and the Company is unable to appoint a
successor depository or (ii) the Depository ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, or (iii) the Company in its sole discretion decides to allow the Notes to be exchanged for
definitive Notes in registered form. Any Notes that are exchangeable pursuant to the preceding sentence are exchangeable for certificated Notes issuable in authorized denominations and registered in such names as the Depository shall direct. As
provided in the Indenture and subject to certain limitations therein set forth, the transfer of definitive Notes in certificated form is registrable in the register maintained by the Company in The City of New York for such purpose, upon surrender
of the definitive Note for registration of transfer at the office or agency of the registrar, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the registrar duly executed by, the holder
thereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or
transferees. Subject to the foregoing, this Note is not exchangeable, except for a Global Security or Global Securities of this issue of the same principal amount to be registered in the name of the Depository or its nominee. 

No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to
cover any tax or other governmental charge payable in connection therewith. 
 Prior to due presentment of this Note for registration of
transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company, the Trustee
nor any such agent shall be affected by notice to the contrary. 
 The Company will pay additional amounts (“Additional Amounts”)
to the beneficial owner of any Note that is a non-United States person in order to ensure that every net payment on such Note will not be less, due to payment of U.S. withholding tax, than the amount then due
and payable. For this purpose, a “net payment” on a Note means a payment by the Company or a paying agent, including payment of principal and interest, after deduction for any present or future tax, assessment or other governmental charge
of the United States. These Additional Amounts will constitute additional interest on the Note. 
 The Company will not be required to pay
Additional Amounts, however, in any of the circumstances described in items (1) through (14) below. 
  

	 	(1)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner:

  

	 	(a)	having a relationship with the United States as a citizen, resident or otherwise; 

  

	 	(b)	having had such a relationship in the past or 

  

	 	(c)	being considered as having had such a relationship. 

  
 7 

	 	(2)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner:

  

	 	(a)	being treated as present in or engaged in a trade or business in the United States; 

  

	 	(b)	being treated as having been present in or engaged in a trade or business in the United States in the past or 

  

	 	(c)	having or having had a permanent establishment in the United States. 

  

	 	(3)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld in whole or in part by reason of the beneficial owner
being or having been any of the following (as such terms are defined in the Internal Revenue Code of 1986, as amended): 

  

	 	(a)	personal holding company; 

  

	 	(b)	foreign private foundation or other foreign tax-exempt organization; 

  

	 	(c)	passive foreign investment company; 

  

	 	(d)	controlled foreign corporation or 

  

	 	(e)	corporation which has accumulated earnings to avoid United States federal income tax. 

  

	 	(4)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner owning or
having owned, actually or constructively, 10 percent or more of the total combined voting power of all classes of stock of the Company entitled to vote or by reason of the beneficial owner being a bank that has invested in a Note as an extension of
credit in the ordinary course of its trade or business. 

 For purposes of items (1) through (4) above, “beneficial owner”
means a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership, limited liability company, corporation or other entity, or a person holding a power over an estate or trust administered by
a fiduciary holder. 
  

	 	(5)	Additional Amounts will not be payable to any beneficial owner of a Note that is a: 

  

	 	(a)	fiduciary; 

  

	 	(b)	partnership; 

  

	 	(c)	limited liability company or 

  

	 	(d)	other fiscally transparent entity 

  
 8 

 or that is not the sole beneficial owner of the Note, or any portion of the Note. However, this
exception to the obligation to pay Additional Amounts will only apply to the extent that a beneficiary or settlor in relation to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally
transparent entity, would not have been entitled to the payment of an Additional Amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment. 

 

	 	(6)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the failure of the beneficial
owner or any other person to comply with applicable certification, identification, documentation or other information reporting requirements. This exception to the obligation to pay Additional Amounts will only apply if compliance with such
reporting requirements is required by statute or regulation of the United States or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge.

  

	 	(7)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is collected or imposed by any method other than by withholding from a
payment on a Note by the Company or a paying agent. 

  

	 	(8)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld by reason of a change in law, regulation, or
administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later. 

  

	 	(9)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is imposed or withheld by reason of the presentation by the beneficial owner
of a Note for payment more than 30 days after the date on which such payment becomes due or is duly provided for, whichever occurs later. 

  

	 	(10)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any: 

  

	 	(a)	estate tax; 

  

	 	(b)	inheritance tax; 

  

	 	(c)	gift tax; 

  

	 	(d)	sales tax; 

  

	 	(e)	excise tax; 

  

	 	(f)	transfer tax; 

  

	 	(g)	wealth tax; 

  
 9 

	 	(h)	personal property tax or 

  

	 	(i)	any similar tax, assessment, withholding, deduction or other governmental charge. 

  

	 	(11)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment, or other governmental charge required to be withheld by any paying agent from a payment of principal or
interest on a Note if such payment can be made without such withholding by any other paying agent. 

  

	 	(12)	Additional amounts will not be payable if a payment on a Note is reduced as a result of any tax, assessment or other governmental charge that is required to be made pursuant to any European Union directive on the
taxation of savings income or any law implementing or complying with, or introduced to conform to, any such directive. 

  

	 	(13)	Additional amounts will not be payable if a payment on a Note is reduced as a result of any withholding, deduction, tax, duty assessment or other governmental charge that would not have been imposed but for a failure by
the holder or beneficial owner of a Note (or any financial institution through which the holder or beneficial owner holds the Note or through which payment on the Note is made) to take any action (including entering into an agreement with the
Internal Revenue Service, or a governmental authority of another jurisdiction if the holder is entitled to the benefits of an intergovernmental agreement between that jurisdiction and the United States) or to comply with any applicable
certification, documentation, information or other reporting requirement or agreement concerning accounts maintained by the holder or beneficial owner (or any such financial institution), or concerning ownership of the holder or beneficial owner, or
any substantially similar requirement or agreement. 

  

	 	(14)	Additional Amounts will not be payable if a payment on a Note is reduced as a result of any combination of items (1) through (13) above. 

Except as specifically provided herein, the Company will not be required to make any payment of any tax, assessment or other governmental
charge imposed by any government or a political subdivision or taxing authority of such government. 
 As used in this Note, “United
States person” means: 
  

	 	(a)	any individual who is a citizen or resident of the United States; 

  

	 	(b)	any corporation, partnership or other entity created or organized in or under the laws of the United States; 

  

	 	(c)	any estate if the income of such estate falls within the federal income tax jurisdiction of the United States regardless of the source of such income and 

 

	 	(d)	any trust if (i) a United States court is able to exercise primary supervision over its administration and one or more United States persons have the authority to control all of the substantial decisions of the
trust or (ii) it has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person. 

  
 10 

 Additionally, “non-United States person” means
a person who is not a United States person, and “United States” means the states of the United States of America and the District of Columbia, but excluding its territories and its possessions. 

Except as provided below, the Notes may not be redeemed prior to maturity. 

 

	 	(1)	The Company may, at its option, redeem the Notes if: 

  

	 	(a)	the Company becomes or will become obligated to pay Additional Amounts as described above; 

  

	 	(b)	the obligation to pay Additional Amounts arises as a result of any change in the laws, regulations or rulings of the United States, or an official position regarding the application or interpretation of such laws,
regulations or rulings, which change is announced or becomes effective on or after April 22, 2015 and 

  

	 	(c)	the Company determines, in its business judgment, that the obligation to pay such Additional Amounts cannot be avoided by the use of reasonable measures available to it, other than substituting the obligor under the
Notes or taking any action that would entail a material cost to the Company. 

  

	 	(2)	The Company may also redeem the Notes, at its option, if: 

  

	 	(a)	any act is taken by a taxing authority of the United States on or after April 22, 2015, whether or not such act is taken in relation to the Company or any affiliate, that results in a substantial probability that
the Company will or may be required to pay Additional Amounts as described above; 

  

	 	(b)	the Company determines, in its business judgment, that the obligation to pay such Additional Amounts cannot be avoided by the use of reasonable measures available to it, other than substituting the obligor under the
Notes or taking any action that would entail a material cost to the Company and 

  

	 	(c)	the Company receives an opinion of independent counsel to the effect that an act taken by a taxing authority of the United States results in a substantial probability that the Company will or may be required to pay the
Additional Amounts described above, and delivers to the Trustee a certificate, signed by a duly authorized officer, stating that based on such opinion the Company is entitled to redeem the Notes pursuant to their terms. 

Any redemption of the Notes as set forth in clauses (1) or (2) above shall be in whole, and not in part, and will be made at a redemption price
equal to 100% of the principal amount of the Notes Outstanding plus accrued interest thereon to the date of redemption. Holders shall be given not less than 30 days’ nor more than 60 days’ prior notice by the Trustee of the date fixed for
such redemption. 

  
 11 

 All terms used in this Note which are defined in the Indenture shall have the meanings assigned
to them in the Indenture. The Notes are governed by the laws of the State of New York. 

  
 12 

 Schedule 1 

Redemptions and Amount of Securities 
  

							
	 Date of partial

redemption
	 	 Aggregate principal amount

of Securities then redeemed
	 	 Remaining principal

amount of this Global

Security
	 	 Authorized Signature

		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	
		 		 		 	

  
 13Nobilis Health Corp. - Exhibit 10.1 - Filed by newsfilecorp.com

PARTNERSHIP INTEREST PURCHASE AGREEMENT 

            This
PARTNERSHIP INTEREST PURCHASE AGREEMENT (this "Agreement"),
dated as of April 18, 2015, is made and entered into by and among Nobilis Health
Holdings Corp., a British Columbia corporation ("Purchaser"), and Victory
Parent Company, LLC, a Texas limited liability company ("VPC"), and
Victory Medical Center Houston GP, LLC, a Texas limited liability company
("GP", together GP and VPC are hereinafter sometimes collectively
referred to as the "Sellers"). Purchaser, Partnership (as hereinafter
defined) and Sellers may be referred to herein individually as a "Party"
and collectively as the "Parties." Capitalized terms not otherwise
defined herein have the meanings set forth in Article I. 

            WHEREAS,
VPC and GP are owners of limited partnership interests and general partnership
interests, respectively, in Victory Medical Center Houston, L.P., a Texas
limited partnership (the "Partnership"), which owns and operates a
licensed general acute care hospital in Houston, Texas (the "Business");

            WHEREAS,
the Partnership is governed by that certain Amended and Restated Limited
Partnership Agreement of Victory Medical Center Houston, L.P. dated July 2013 as
amended by that certain First Amendment to Limited Partnership Agreement of
Victory Medical Center Houston, L.P. dated June 3, 2013 (collectively, the
"Partnership Agreement"); 

            WHEREAS,
VPC owns a Partnership Interest (as defined in the Partnership Agreement) equal
to 54.75%, and GP owns all of the GP Units (as defined in the Partnership
Agreement) representing a Partnership Interest of .25% ; and 

            WHEREAS,
Purchaser desires to purchase, and Sellers desire to sell, all of the Units (as
defined in the Partnership Agreement) owned by VPC (the "Limited Partnership
Interests") and all of the Units owned by GP (the "General Partnership
Interests"), currently held by VPC and GP (collectively the "Purchased
Interests"), all upon the terms and conditions of this Agreement; 

            NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth
in this Agreement, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties hereto agree as
follows: 

ARTICLE I. 
DEFINITIONS 

            As
used herein, the following terms shall have the following meanings: 

            "Affiliate"
means, with respect to any Person, any other Person directly or indirectly
controlling, controlled by or under common control with such Person. For the
purposes of this Agreement, "control," when used with respect to any
Person, means the possession, directly or indirectly, of the power to (a) vote
10% or more of the securities having ordinary voting power for the
election of directors (or comparable positions) of such Person or (b) direct or
cause the direction of the management and policies of such Person, whether
through the ownership of voting securities, by contract or otherwise, and the
terms "controlling" and "controlled" have meanings consistent with
the foregoing. 

Execution Version 

  Partnership Interest Purchase Agreement

            
"Agreement" has the meaning specified in the preamble to this Agreement.

           
"Assumption Agreement" has the meaning set forth in Section 3.1(d) . 

           
"Balance Sheet Date" means February 28, 2015. 

            "Business
Day(s)" means a day other than Saturday, Sunday or any day on which banks
located in the State of Texas are authorized or obligated to close. 

           
"Cash Consideration" has the meaning set forth in Section 3.1. 

           
"Closing" means the closing of the transactions contemplated by ARTICLE
III. 

            "Closing
Date" means the date on which the Closing actually occurs.

           
"Code" means the Internal Revenue Code of 1986, as amended. 

            "Contracts"
means any contracts, agreements, subcontracts, leases, notes, indentures,
commitments, memoranda of understanding and purchase orders, whether written or
oral and each amendment, supplement, or modification (whether written or oral)
in respect of any of the foregoing, in each case as currently in effect. 

            "Employee
Benefit Plan" means any (a) nonqualified deferred compensation or retirement
plan or arrangement that is an Employee Pension Benefit Plan, (b) qualified
defined contribution retirement plan or arrangement that is an Employee Pension
Benefit Plan, (c) qualified defined benefit retirement plan or arrangement that
is an Employee Pension Benefit Plan (including any Multiemployer Plan), (d)
Employee Welfare Benefit Plan or material fringe benefit plan or program, (e)
plan that would be an "employee benefit plan" as such term is defined in ERISA
Section 3.3 if it was subject to ERISA, (f) equity bonus, equity ownership,
equity option, equity purchase, equity appreciation rights, phantom equity or
other equity plan, (g) bonus or incentive compensation plan, or (h) holiday or
vacation practice or other paid-time off program, or workers compensation plan
or program, in each case, that is or has been maintained, sponsored, contributed
to, or required to be contributed to by Partnership or any of its Affiliates for
the benefit of any current or former employee, director, retiree, independent
contract or consultant, or any spouse or dependent, or with respect to which
Partnership or any of its Affiliates may have any liability. 

           
"Employee Pension Benefit Plan" has the meaning specified in ERISA
Section 3.2. 

            "Employee
Welfare Benefit Plan" has the meaning specified in ERISA Section 3.1. 

            "Environment"
means soil, land surface or subsurface strata, waters (including, navigable
ocean, stream, pond, reservoirs, drainage, basins, wetland, ground, and
drinking), sediments, ambient air (including indoor), noise, plant life, animal
life, and all other environmental media or natural resources. 

            "Environmental,
Health, and Safety Requirements" means all orders, Contracts, Laws, and
programs (including those promulgated or sponsored by industry associations,
insurance companies, and risk management companies) concerning or
relating to public health and safety, worker/occupational health and safety, and
pollution or protection of the Environment, including those relating to the
presence, use, manufacturing, refining, production, generation, handling,
transportation, treatment, transfer, storage, disposal, distribution, importing,
labeling, testing, processing, discharge, Release, threatened Release, control,
or other action or failure to act involving cleanup of any Hazardous Materials,
substances or wastes, chemical substances or mixtures, pesticides, pollutants,
contaminants, toxic chemicals, petroleum products or byproducts, asbestos,
polychlorinated biphenyls, noise, or radiation, each as amended and as now in
effect. 

2 

            "Equipment
Leases" has the meaning set forth in Section 3.1(d) . 

            "ERISA"
means Employee Retirement Income Security Act of 1974, as amended. "GAAP"
means generally accepted United States accounting principles. 

            "Guaranty
Replacement" or "Guaranty Replacements" shall have the meaning set
forth in Section 3.1(d) . 

            "General
Partner" shall mean the general partner of Partnership. 

            "General
Partnership Interests" has the meaning set forth in the recitals. 

            "Governmental
Authority" means any national, federal, state, county, municipal, local or
foreign government, or other political subdivision thereof and any entity
exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to government. 

            "Hazardous
Materials" shall mean any (a) pollutants, contaminants, and toxic or
hazardous materials or substances, (b) solid wastes, including asbestos,
polychlorinated biphenyls, mercury, buried contaminants, chemicals, flammable or
explosive materials, (c) radioactive materials or radiation, (d) petroleum
wastes and spills or Releases of petroleum products, and (e) any other material
or substance the storage, manufacture, disposal, treatment, generation, use,
transport, mediation or Release into the Environment of which is prohibited,
controlled, regulated, or licensed under any Environmental, Health, and Safety
Requirements. 

            "Hospital"
shall mean the licensed general acute care hospital located in Houston, Texas
owned and operated by the Partnership. 

            "Indebtedness"
means, with respect to a Person, any obligations of such Person: (a) for
borrowed money, including related fees and expenses; (b) evidenced by notes,
bonds, debentures or similar instruments; (c) for the deferred purchase price of
goods or services (other than trade payables or accruals incurred in the
ordinary course of business consistent with past practices); (d) all obligations
under terms that are or should be, in accordance with GAAP, recorded as capital
leases; (e) liabilities in respect of unfunded vested benefits under any
Employee Benefit Plan; (f) all customer deposits or (g) in the nature of
guarantees of the obligations described in clauses (a) through (f)
above of any other Person. 

            "Intercompany
Debt" has the meaning set forth in Section 3.1(c) . 

3 

            "Knowledge"
and any other similar phrase or variation thereof means the knowledge, following
such inquiries and investigations as would be deemed appropriate by a reasonable
businessperson engaged in a the ownership and operation of a general acute care
hospital, of Robert N. Helms, Jr., Ivan Wood and Robert Garcia. 

            "Laws"
means all federal, state, local or foreign laws, legislation, statutes,
constitutions, rules, regulations, codes, edicts, orders, judgments,
decrees, ordinances, or legally-binding directives, guidance or pronouncements
or rules of common law of any Governmental Authority. 

            "Liabilities"
has the meaning specified in Section 4.5(b) . 

            "Licenses"
means all of the licenses, permits, certificates, exemptions, franchises and
other authorizations from any Governmental Authority or other third party
necessary or proper for the use, occupancy or operation of the Hospital as
conducted as of the Closing Date. 

            "Lien"
means any claim, lien, pledge, option, right of first refusal, easement,
security interest, deed of trust, mortgage, right-of-way, encroachment,
restrictive covenant or other encumbrance, whether voluntarily incurred or
arising by operation of law, and includes, without limitation, any agreement to
give any of the foregoing in the future, and any contingent or conditional sale
agreement or other title retention agreement or lease in the nature thereof.

           
"Limited Partners" shall mean the limited partners of the Partnership.

           
"Limited Partnership Interests" has the meaning set forth in the
recitals. 

           
“Material Asset” has the meaning specified in Section 4.7. 

           
“Material Asset Contract” has the meaning specified in Section 4.7. 

           
"Multiemployer Plan" has the meaning specified in ERISA Section 3(37).

           
"Partnership" has the meaning set forth in the recitals.

           
"Partnership Promissory Note" has the meaning set forth in Section 3.1(c)
.. 

           
"Party" or "Parties" has the meaning specified in the preamble to
this Agreement. 

            "Person"
means any individual, corporation, partnership, joint venture, association,
joint-stock company, trust, unincorporated organization, limited liability
company or government or other entity. 

            "Proceeding"
means any action, complaint, suit, litigation, arbitration or proceeding
(including any civil, criminal, administrative, investigative or appellate
proceeding), hearing, inquiry, review, audit, examination or investigation
commenced, brought, conducted or heard by or before, or otherwise involving any
court, tribunal or other Governmental Authority or any arbitrator or arbitration
panel. 

            "Purchase
Price" has the meaning specified in Section 3.1. 

4 

            "Purchased
Interests" has the meaning set forth in the recitals. 

            "Purchaser"
has the meaning specified in the preamble to this Agreement. 

            "Purchaser
Promissory Note" has the meaning specified in Section 3.1(c) . 

            "Real
Estate Lease" has the meaning set forth in Section 7.5. 

            "Release"
means any spilling, leaking, emitting, discharging, depositing, escaping,
leaching, dumping, or other release into the Environment. 

            
"Tax" or "Taxes" means (a) any and all federal, state, local, or
foreign income, gross receipts, license, payroll, employment, excise, severance,
stamp, occupation, premium, windfall profits, environmental (including taxes
under Section 59A of the Code), customs duties, capital stock, franchise,
margin, profits, withholding, social security (or similar), unemployment,
disability, real property, personal property, sales, use, transfer,
registration, value added, alternative or add-on minimum, estimated, or other
tax, premium, contribution, charge, assessment or duty of any kind whatsoever,
wheresoever chargeable and whether in the United States of any other
jurisdiction, including any interest, penalty, or addition thereto and any
interest in respect of such penalties or additions, whether disputed or not, (b)
any liability for the payment of any item described in clause (a) as a result of
being a member of an affiliated, consolidated, combined, unitary, or aggregate
group for any period, including pursuant to Treasury Regulations Section 1.1502
-6 (or any analogous or similar provisions under state, local or foreign Law);
(c) any liability for the payment of any item described in clause (a) or (b) as
a result of any express or implied obligation to indemnify any Person or as a
result of any obligations under any agreements or arrangements with any Person
with respect to such item; or (d) any successor or transferee liability for the
payment of any item described in clause (a), (b) or (c) of any Person, including
by reason of being a party to any merger, consolidation, conversion or
otherwise. 

            "Tax
Return" means any return, declaration, report, claim for refund, or
information return or statement relating to Taxes, including any schedule or
attachment thereto, and including any amendment thereof. 

            "Third
Party Non-Tax Claim" means a Third Party Claim that does not pertain to
Taxes. 

            "UMB
Notes" has the meaning specified in Section 3.1(c) . 

            "VPC
Properties" has the meaning set forth in Section 7.5. 

ARTICLE II. 
PURCHASE AND SALE OF PURCHASED
INTERESTS 

            2.1       
Purchase and Sale of Purchased Interests. On the Closing Date, subject to
the terms set forth herein, Purchaser shall purchase from Sellers, and Sellers
shall sell to Purchaser, the Purchased Interests, free and clear of all claims,
encumbrances, Proceedings, debts, demands or liabilities of any kind. With
respect to the purchases described above, Purchaser shall purchase the General
Partnership Interests from the GP, and GP shall sell to Purchaser or Purchaser's assigns the General Partnership Interests, and
Purchaser or its assigns shall purchase the Limited Partnership Interests from
VPC, and VPC shall sell to Purchaser or its assigns, the Limited Partnership
Interests, all of the foregoing being free and clear of all claims,
encumbrances, Proceedings, debts, demands or liabilities of any kind. 

5 

ARTICLE III. 
PURCHASE PRICE; CLOSING; WORKING
CAPITAL ADJUSTMENT 

            3.1       
Purchase Price. The aggregate consideration payable by Purchaser, or an
assignee of Purchaser, to Sellers for the Purchased Interests (the "Purchase
Price") shall be as follows: 

                          (a)       
One Million Five Hundred Thousand and No/100 Dollars ($1,500,000.00)(the
"Cash Consideration"), which shall be non-refundable and payable upon
execution of this Agreement, by wire transfer in immediately available funds as
designated by VPC on Schedule 3.1(a). Notwithstanding the foregoing, in
the event the Agreement is executed after the close of business or on a day that
is not a Business Day, the funds will be wired on the next Business Day; plus

                          (b)       
(Intentionally omitted); plus 

                          (c)       
The assumption of the aggregate outstanding intercompany debt owed by Sellers to
the Partnership as specifically set forth on Schedule 3.1(c) (the
"Intercompany Debt"), which shall be evidenced by a promissory note from
Purchaser in favor of the Partnership (the "Purchaser Promissory Note")
in substantially the same form as the promissory note attached to this Agreement
as Exhibit B, and cause the Partnership to release Sellers from any
further obligations or liabilities related to the Intercompany Debt; plus 

                          (d)       
The assumption of all obligations or other liabilities of Sellers under all
applicable Material Asset Contracts listed on Schedule 3.1(d) as evidenced by an
assignment and assumption agreement (the "Assumption Agreement") and
consented to by the lessors, if applicable, and the exercise of all commercially
reasonable efforts to remove or replace Sellers, as soon as reasonably
practicable, from any and all warranties, guarantees, liabilities or other
obligations relating to the Material Asset Contracts (collectively, the
"Guaranty Replacements" and each a “Guaranty Replacement”). From
and after the Closing Date, Purchaser shall indemnify and hold harmless VPC, in
accordance with ARTICLE IX below, from any default with respect to the Material
Asset Contracts assumed by Purchaser or Purchaser’s assignee. In the event any
Guaranty Replacement required under this subsection has not been accomplished
within sixty (60) days of Closing, Purchaser shall cause the Partnership to pay
Sellers 1% per month of the outstanding balance of the applicable Material Asset
Contract. For purposes of this Section 3.1(d), the Parties hereto acknowledge
and agree that both Robert N. Helms, Jr. and Harsad D. Patel are third party
beneficiaries with respect to the indemnification obligations of Purchaser upon
a default as described hereunder. 

            3.2       
Closing. Subject to the satisfaction or waiver by the applicable party of
the conditions precedent to the Closing as specified in ARTICLE VI and ARTICLE
VII below, the Closing will take place at a time determined by the Purchaser as
soon as practicable after execution but in no event later than April 24, 2015.
Purchaser shall provide the Sellers no less than two Business Days' notice of the date the Purchaser as
elected for Closing. The Closing shall be effective as of 11:59 p.m. on the
Closing Date. 

6 

            3.3       
Deliveries of Sellers at Closing. At Closing, Sellers shall deliver or
cause to be delivered to Purchaser: 

                          (a)       
counterparts of an Assignment of Limited Partnership Interests in a form
reasonably satisfactory to Purchaser; 

                          (b)       
counterparts of an Assignment of General Partnership Interests in a form
reasonably satisfactory to Purchaser; 

                          (c)       
a duly executed Partnership Promissory Note, executed by the Partnership; 

                          (d)       
an Officers' Certificate, in form and substance reasonably satisfactory to
Purchaser, duly executed on VPC's behalf, certifying as to (i) the charter
documents and organizational documents of VPC, (ii) the resolutions relating to
the authority of VPC to enter into the transactions contemplated by this
Agreement, and (iii) that the conditions in ARTICLE VI have been satisfied; 

                         (e)       
an Officers' Certificate, in form and substance reasonably satisfactory to
Purchaser, duly executed on GP's behalf, certifying as to (i) the charter
documents and organizational documents of GP, (ii) the resolutions relating to
the authority of GP to enter into the transactions contemplated by this
Agreement, (iii) the resolutions, which shall specifically include the consent
of GP, authorizing the Partnership to make the Partnership Promissory Note and
to accept the Purchaser Promissory Note, and (iv) that the conditions in ARTICLE
VI have been satisfied; 

                          (f)       
evidence or copies of the consents, approvals, orders, qualifications or waivers
required by any third party or Governmental Authority to consummate the
transactions contemplated by this Agreement; and 

                          (g)       
the Partnership’s books and records maintained by or in the possession of
Sellers; and 

                          (h)       
such other documents or instruments as are required to be delivered at the
Closing pursuant to the terms hereof. 

            3.4       
Deliveries of Purchaser at Closing. At Closing, Purchaser shall deliver
or cause to be delivered to Sellers: 

                          (a)       
a duly executed copy of the Guaranty Replacements, in accordance with Section
3.1(d); 

                          (b)       
[INTENTIONALLY OMITTED] 

                          (c)       
a duly executed copy of the Purchaser Promissory Note; 

7 

                          (d)       
a counterpart to the General Partnership Interests Assignment, duly executed by
GP; 

                         
(e)        an Officer's Certificate, in form
and substance reasonably satisfactory to Sellers, duly executed on Purchaser's
behalf, certifying as to (i) the charter documents and organizational documents
of Purchaser. and (ii) the resolutions relating to the authority of Purchaser to
enter into the transactions contemplated by this Agreement; 

                         
(f)        evidence of good standing from the
applicable British Columbia authority that Purchaser is existing and in good
standing under the Laws of the British Columbia, Canada; and 

                         
(g)        such other documents or
instruments as Purchaser reasonably deems necessary to effect the transaction
contemplated hereby or that are required to be delivered at the Closing pursuant
to the terms hereof. 

            3.5       
Surplus or Deficit of Paid Closing Receivables and Paid Closing Payables.
VPC shall be entitled to receive from the Partnership an amount equal to 55% of
any surplus equal to the difference between the aggregate amount of the
Partnership's trade payables owed as of the Closing Date (the "Payables")
and the aggregate amount of any outstanding accounts receivable as of the
Closing Date (the "Receivables") that have been paid through the date
that is the one (1) year anniversary of the Closing Date (the "Surplus
Payment"). The Partnership shall be entitled to receive from VPC an amount
equal to 55% of any deficit equal to the difference between the aggregate amount
of Payables and the aggregate amount of Receivables that have been paid through
the date that is the one (1) year anniversary of the Closing Date (the
"Deficit Payment"). Purchaser shall cause the Partnership to make the
Surplus Payment, or VPC shall make the Deficit Payment, as applicable, no later
than ten (10) Business Days from the date that is the one (1) year anniversary
of the Closing Date 

            3.6       
Operational Expenses of the Partnership. Notwithstanding anything to the
contrary contained herein, between execution of this Agreement and Closing,
Purchaser will loan the Partnership any and all funds necessary to operate the
Business, including the operations of the Hospital, which such expenses shall
include but not be limited to payroll, supplies, rent and utilities. Purchaser
shall pay such expenses directly upon Purchaser's approval, which shall not be
unreasonably withheld, after receipt of reasonable documentation of such
expenses from the Partnership.

            3.7       
Additional Acts. Further, from time to time after the Closing, each party
shall execute and deliver such other instruments of conveyance and transfer, and
take such other actions as another party hereto may reasonably request, to more
effectively convey and transfer full right, title and interest to, vest in, and
place each party, in legal and actual possession of, as applicable, the
Purchased Interest. 

ARTICLE IV. 
REPRESENTATIONS AND WARRANTIES OF
SELLERS 

           
Each of VPC and GP represent and warrant to Purchaser, jointly-and-severally, as
of the Closing Date, as follows:

 8 

            4.1       
Organization and Qualification of Partnership. Partnership is a limited
partnership, duly formed and validly existing under the Laws of the State of
Texas. Partnership has the requisite company power and authority to own, operate
or lease the properties and assets now owned, operated or leased by it and to
carry on the Business as currently conducted by Partnership. Partnership is duly
qualified to do business as a foreign limited partnership and is in good
standing in each jurisdiction where the character of its properties owned,
operated or leased or the nature of its activities makes such qualification
necessary. 

            4.2       
Capitalization of Partnership; Subsidiaries. As of the Closing Date, the
partners set forth on Schedule 4.2 are the record and beneficial owners
of 100% of the partnership interests and other equity interests in Partnership.
Except for those partners set forth on Schedule 4.2, no others
have any right to vote as partners on matters relating to Partnership or the
right to receive economic benefit as partners. There are no outstanding
warrants, options or rights of any kind to acquire from Partnership any equity
interest in Partnership. The Partnership has no subsidiaries. 

            4.3       
Capacity; Enforceability. VPC and GP each have all requisite power,
capacity and authority to execute and deliver this Agreement and to perform
their respective obligations hereunder. This Agreement has been duly and validly
executed and delivered by, and is a valid and binding obligation of, VPC and GP,
enforceable against VPC and GP, as applicable, in accordance with its terms,
except as the enforceability may be limited by (a) applicable bankruptcy,
insolvency, moratorium, reorganization, fraudulent conveyance or similar Laws in
effect which affect the enforcement of creditors' rights generally; or (b)
general principles of equity. As of the Closing there will no encumbrance on the
Limited Partnership Interest or the General Partnership Interest.

            4.4       
Consents and Approvals. Except for any consents required by (a) the Texas
Department of State Health Services and (b) VPC's or GP's lender, no consent,
authorization or approval of, or filing or registration with any Governmental
Authority or any other Person is necessary in connection with the execution,
delivery or performance by VPC or GP of this Agreement or the consummation by
VPC and GP of the transactions contemplated herein. Except as set forth on
Schedule 4.4 and subject to the approval of VPC's and GP's lender, neither VPC,
GP or Partnership is a party to, subject to or bound by (or by which any of its
properties or assets may be bound) any Contract which does or would (a) conflict
with or be breached or violated or the obligations thereunder accelerated or
increased (whether or not with notice or lapse of time, or both) or give rise to
any payment obligation or loss of a benefit, or a right of termination,
cancellation, or modification, by the execution, delivery or performance by VPC
or GP of this Agreement, or (b) prevent the carrying out of the transactions
contemplated herein. 

            4.5       
Financial Statements; No Undisclosed Liabilities; Absence of Changes.

                          (a)       
Sellers have delivered to Purchaser: (a) an unaudited balance sheet of
Partnership as of December 31, 2014, and the related unaudited statements of
income and cash flows for the year then ended; (b) an audited balance sheet and
the related audited statements of income and cash flows as of December 31 for
each of the years 2013 and 2012; and (c) an unaudited balance sheet of Seller as
of March 31, 2015 ("Balance Sheet Date") and the related statements of
income for the three (3) months then ended. Such financial statements fairly and
accurately present the financial condition and the results of
operations and cash flows of Partnership on the respective dates of and for the
periods referred to in such financial statements. The financial statements
referred to in this Section were prepared in accordance with GAAP consistently
applied throughout the periods involved. The financial statements have been and
will be prepared from and are in accordance with the accounting records of
Partnership. Other than as set forth on Schedule 4.5, Partnership does
not have any long-term debt.

9 

                          (b)       
Partnership has no liabilities, obligations or commitments of any nature
whatsoever, asserted or unasserted, known or unknown, absolute or contingent,
accrued or unaccrued, matured or unmatured or otherwise ("Liabilities"),
except (a) those which are adequately reflected or reserved against in the
balance sheet as of the Balance Sheet Date, and (b) those which have been
incurred in the ordinary course of business consistent with past practice since
the Balance Sheet Date and which are not, individually or in the aggregate,
material in amount; 

                         
(c)        Since the Balance Sheet Date, and
other than in the ordinary course of business consistent with past practice,
there has not been, with respect to the Partnership, any: 

                                        
(i)        event, occurrence or development
that has had, or could reasonably be expected to have, individually or in the
aggregate, a material adverse effect; 

                                       
(ii)        amendment of the certificate of
limited partnership, limited partnership agreement or other organizational
documents of the Partnership; 

                                       
(iii)        split, combination or
reclassification of any Units of partnership interests, the issuance, sale or
other disposition of any Units of partnership interests, or grant of any
options, warrants or other rights to purchase or obtain (including upon
conversion, exchange or exercise) any of Units of partnership interests, the
declaration or payment of any or distributions on or in respect of any Units of
partnership interests or the redemption, purchase or acquisition of Units of
partnership interests; 

                                       
(iv)        material change in any method of
accounting or accounting practice of the Partnership, except as required by GAAP
or as disclosed in the notes to the financial statements; 

                                       
(v)        material change in the
Partnership's cash management practices and its policies, practices and
procedures with respect to collection of accounts receivable, establishment of
reserves for uncollectible accounts, accrual of accounts receivable, inventory
control, prepayment of expenses, payment of trade accounts payable, accrual of
other expenses, deferral of revenue and acceptance of customer deposits; 

                                       
(vi)        incurrence, assumption or
guarantee of any indebtedness for borrowed money except unsecured current
obligations and Liabilities incurred in the ordinary course of business
consistent with past practice; 

                                       
(vii)        transfer, assignment, sale or
other disposition of any of the assets shown or reflected in the balance sheet
or cancellation of any debts or entitlements, or any material damage,
destruction or loss (whether or not covered by insurance) to its property; 

10 

                                      (viii)    
 any capital investment in, or any loan to, any other Person; 

                                     
(ix)        acceleration, termination,
material modification to or cancellation of any material Contract (including,
but not limited to, any material Contract) to which the Partnership is a party
or by which it is bound; 

                                       
(x)        any material capital expenditures;

                                       
(xi)        imposition of any Lien upon any
of the Partnership properties, Partnership Interest or assets, tangible or
intangible; 

                                       
(xii)       any loan to (or forgiveness of any
loan to), or entry into any other transaction with, any of its stockholders or
current or former directors, officers and employees; 

                                       
(xiii)      adoption of any plan of merger,
consolidation, reorganization, liquidation or dissolution or filing of a
petition in bankruptcy under any provisions of federal or state bankruptcy Law
or consent to the filing of any bankruptcy petition against it under any similar
Law; 

                                       
(xiv)      purchase, lease or other acquisition of the
right to own, use or lease any property or assets for an amount in excess of
$5,000, individually (in the case of a lease, per annum) or $25,000 in the
aggregate (in the case of a lease, for the entire term of the lease, not
including any option term), except for purchases of inventory or supplies in the
ordinary course of business consistent with past practice; or 

                                       
(xv)       action by GP or the Partnership to
make, change or rescind any Tax election, amend any Tax Return or take any
position on any Tax Return, take any action, omit to take any action or enter
into any other transaction that would have the effect of increasing the Tax
liability or reducing any Tax asset of Purchaser in respect of any post-Closing
Tax Period 

            4.6       
Contracts; No Defaults. Except as set forth on Schedule 4.6,
neither Partnership nor VPC is in material default of any Contract or agreement
except where such default would not result in any effect or change that would be
materially adverse to the Business, assets, condition (financial or otherwise),
operating results, operations, or business prospects of Partnership taken as a
whole, or to the ability of any Party to this Agreement to consummate the
transactions contemplated herein. 

            4.7       
Asset Sufficiency, Condition of Tangible Property. Schedule 4.7, which
shall be delivered, no later than the close of business on April 21, 2015,
contains a list of all assets (“Material Assets”) reasonably necessary to
operate the Business and the Hospital in the same manner as currently conducted
and as conducted during the one (1) year period immediately preceding the
Closing Date. The Partnership represents and warrants that (i) the Material
Assets represent all of the assets necessary to operate the Business and the
Hospital in the same manner as currently conducted and as conducted during the
one (1) year period immediately preceding the Closing Date. Notwithstanding the
foregoing, Partnership reserves the right to supplement Schedule 4.7
prior to Closing Date. 

11 

            4.8       
Litigation and Proceedings. Except as set forth on Schedule 4.8,
there are no claims or Proceedings pending or threatened, against or affecting
VPC, GP or the Partnership at law or in equity, or before or by any Governmental
Authority, which if determined adversely to VPC, GP or the Partnership would
have a material adverse effect on the operations or finances of Partnership.

            4.9       
Employee Benefit Plans. Partnership does not currently maintain any
Employee Benefit Plans and any Employee Benefit Plans previously maintained by
Partnership were terminated in accordance with the plan documents and applicable
Law. 

            4.10    
 Labor Matters. (a) Partnership has not been, and is not now, a
party to any collective bargaining agreement or other labor Contract; (b) there
has not been, there is not presently pending or existing and, to the Knowledge
of Sellers, there is not threatened, any strike, slowdown, picketing, work
stoppage or employee grievance process involving Seller; (c) to the Knowledge of
Seller no event has occurred and no circumstances exist that could provide the
basis for any work stoppage or other labor dispute; (d) to the Knowledge of
Seller no application or petition for an election of or for certification of a
collective bargaining agent is pending; and (e) to the Knowledge of Seller,
there has been no charge of discrimination filed against or threatened against
Seller with the Equal Employment Opportunity Commission or similar Governmental
Entity 4.11 Taxes. Except as set forth on Schedule 4.11, Partnership has
(a) timely filed or extended all returns required to be file by or in respect of
the Business with respect to all Taxes; (b) paid all Taxes shown to have become
due pursuant to such returns; and (c) paid all other Taxes for which a notice of
assessment or demand for payment has been received, if the due date therefore
has occurred. Partnership has not received any notice of any proposed
assessments of Taxes against or in respect of the Business, or any proposed
adjustments to any Tax Returns filed by or in respect of the Business. 

            4.12    
 Insurance. Partnership maintains insurance coverage for its
operations, personnel and assets. Schedule 4.12 sets forth all insurance
policies to which the Partnership is a party, an insured or a beneficiary and
these insurance policies as well as a list of all pending insurance claims
related to the Partnership. All of the policies set forth on Schedule
4.12 are valid, outstanding and enforceable, are issued by an insurer that
is financially sound and reputable, and, taken together, provide the Partnership
with (i) adequate insurance coverage for the assets and operations of the
Partnership, the Business and the Hospital, and (ii) all such coverage as is
required by Laws, Licenses and Governmental Authorities which govern or oversee
the Partnership, the Business and the Hospital. No insurance carrier has
canceled or reduced or given notice of its intention to cancel or reduce, any
insurance coverage with respect to the Business and to the Knowledge of Seller
there are no grounds to cancel or void any such policies or coverage. 

            4.13    
 Brokers. No broker, finder, investment banker or other Person is
entitled to any brokerage fee, finders' fee or other commission in connection
with the transactions contemplated by this Agreement based upon arrangements
made by Partnership. 

12 

            4.14    
 Compliance with Laws. Partnership is and prior to the Closing has
been, in material compliance with all applicable Laws. Partnership possesses and
is in compliance in all material respects with all Licenses required by it under
all Laws in connection with the conduct of the Business as presently conducted,
including all applicable anti-money laundering and economic sanctions Laws. No
loss or expiration of any such License is pending or threatened or reasonably
foreseeable, other than expiration in accordance with the terms thereof of
Licenses that may be renewed in the ordinary course of business without lapsing
.. 

            4.15    
 Environmental Matters. Partnership is in material compliance with
all Environmental, Health and Safety Requirements. Partnership has not received
from an Person any (x) notice or claim that Partnership is in violation of any
Environmental, Health and Safety Requirement or (y) any request for information
related to any asserted violation of any Environmental, Health and Safety
Requirement. 

            4.16    
 Real Property. Partnership does not own any real property. The real
property on which the Hospital is located is provided to Partnership under the
terms of a lease agreement. To the Knowledge of Sellers, Partnership is in
material compliance with the terms and conditions of such lease agreement and is
not currently in material default of the terms and conditions of such agreement.

            4.17     
Regulatory Compliance; Improper Payments. 

                          (a)       
The Hospital has at all times remained in constant operation and no event has
occurred which could result in the suspension or termination of any License
required to operate the Hospital; 

                         
(b)        Sellers and the Partnership have
been and are presently in material compliance with all applicable Legal
Requirements, including Title XVIII of the Social Security Act, 42 U.S.C. §§
1395-1395hhh (the Medicare statute), including specifically, but not limited to,
the Ethics in Patient Referrals Act, as amended, or "Stark Law," 42 U.S.C. §
1395nn; Title XIX of the Social Security Act, 42 U.S.C. §§ 1396-1396v (the
Medicaid statute); the Federal Health Care Program Anti-Kickback Statute, 42
U.S.C. § 1320a-7b(b); the False Claims Act, as amended, 31 U.S.C. §§ 3729-3733;
the Program Fraud Civil Remedies Act, 31 U.S.C. §§ 3801-3812; the Anti-Kickback
Act of 1986, 41 U.S.C. §§ 51-58; the Civil Monetary Penalties Law, 42 U.S.C. §§
1320a-7a and 1320a-7b; the Exclusion Laws, 42 U.S.C. § 1320a-7; the Health
Insurance Portability and Accountability Act of 1996 as amended by the Health
Information Technology for Economic and Clinical Health Act (collectively,
"HIPAA") and all applicable implementing regulations, rules, ordinances
and orders; and any similar state and local statutes, regulations, rules,
ordinances and orders that address the subject matter of the foregoing. 

                          (c)       
Neither Sellers nor the Partnership has received any notice from any agency,
board, commission, bureau, intermediary, carrier, Medicare administrative
contractor, Government Program integrity contractor, recovery audit contractor,
accreditation organization or other instrumentality of any government, whether
federal, state or local, commercial payor or patient that any of the operations
of the Partnership are not in compliance with all applicable Law or
accreditation requirements. Sellers and the Partnership have timely filed all
reports, data and other information required to be filed pursuant to the Legal
Requirements. Notwithstanding the foregoing, Government Program requests for information as
part of the 855A application process shall not be deemed to be regulatory
non-compliance pursuant to this Section 4.17. 

13 

                          (d)       
Except in compliance with the applicable Law, neither Sellers nor Partnership
nor any member, manager, officer or employee of Sellers or Partnership, nor any
agent acting on behalf of or for the benefit of any of the foregoing, has
directly or indirectly: (i) offered, paid, solicited, or received any
remuneration (including any kickback, bribe, or rebate), in cash or in kind, to,
or made any financial arrangements or a gratuitous payment of any kind, with any
past, present or potential customers, past, present, or potential suppliers,
patients, government officials, physicians, contractors or third party payors of
Sellers or Partnership or any other person or entity in exchange for business or
payments from such persons in violation of Legal Requirements; (ii) established
or maintained any unrecorded fund or asset for any improper purpose or made any
misleading, false, or artificial entries on any of its books or records for any
reason; or (iii) made any payment for or agreed to make any payment for any
goods, services, or property in excess of fair market value except to the extent
permitted by applicable Law. 

                          (e)       
Except in compliance with applicable Law, neither Sellers nor, to the Knowledge
of any Sellers, any member, manager, officer or employee of Sellers is a party
to any Contract, lease agreement or other arrangement (including any joint
venture or consulting agreement) related to Sellers, the Partnership or the
Partnership's assets with any physician, immediate family member of a physician,
physical or occupational therapist, health care facility, hospital, nursing
facility, home health agency or other person who is in a position to make or
influence referrals to or otherwise generate business for Sellers, the
Partnership or the Partnership's assets. 

                          (f)       
Sellers and the Partnership maintain a compliance program designed to promote
compliance with all applicable Laws, rules, and regulations and ethical
standards, to improve the quality and performance of operations, and to detect,
prevent, and address violations of legal or ethical standards applicable to the
operations of the Partnership (a "Compliance
Program"). Sellers has delivered to Purchaser a complete
and accurate copy of the Partnership's current Compliance Program materials,
including all program descriptions, compliance officer and committee
descriptions, ethics and risk area policy materials, training and education
materials, auditing and monitoring protocols, reporting mechanisms, and
disciplinary policies, and Sellers and the Partnership have conducted their
operations in accordance with such Compliance Program. Neither Sellers nor the
Partnership (i) is a party to a Corporate Integrity Agreement with the Office of
Inspector General of the Department of Health and Human Services, (ii) has
reporting obligations pursuant to any settlement agreement entered into with any
governmental authority, (iii) to the knowledge of Sellers has been the subject
of any health care program investigation or been served with or received any
search warrant, subpoena, civil investigative demand, contact letter, or
telephone or personal contact by or from any governmental authority regarding
any healthcare program investigation conducted by any governmental authority,
(iv) to the knowledge of Sellers, is or has been a defendant in any qui
tam/False Claims Act litigation, or (v) has received any complaints from
employees, independent contractors, vendors, physicians, or any other person
that would indicate that Sellers or the Partnership have violated in any
material respect any applicable Law. Sellers have provided Sellers with complete and accurate descriptions of each audit
and investigation conducted pursuant to the Compliance Program during the last
three (3) years. 

14 

                          (g)       
All employed personnel who work in or provide services at the Partnership have
all applicable authorizations, Licenses and registrations from the State of
Texas and other applicable governmental authorities to render the medical
services and ancillary services currently provided. 

                          (h)       
The Partnership has not previously maintained and does not currently maintain a
Medicare provider agreement. 

            4.18     
Medical Staff Matters. Sellers have provided to Purchaser complete and
accurate copies of the medical staff bylaws, medical staff rules and
regulations, and medical staff hearing procedures of the Partnership, all as
presently in effect. There are no pending or, to the Knowledge of Sellers,
threatened adverse actions, appeals, challenges, disciplinary or corrective
actions, or disputes involving applicants to the medical staff of the
Partnership, current members of the medical staff of the Partnership or
affiliated health professionals, and all appeal periods in respect of any
medical staff member, allied health professional or applicant against whom an
adverse action has been taken by the Partnership have expired. Sellers have
delivered to Purchaser a written disclosure containing a brief general
description of all material adverse actions taken in the six months prior to the
date hereof against the Partnership's medical staff members, allied health
professionals or applicants which could result in claims or actions against the
Partnership. There are no Proceedings pending or threatened against or affecting
any member of the medical staff of the Partnership at law or in equity, or
before or by any federal, state, municipal or other governmental department,
commission, board, bureau, agency or instrumentality wherever located relating
to medical practice or conduct in connection therewith. 

            4.19    
 Information Privacy and Security Compliance.

                          (a)       
Sellers and the Partnership (i) to the extent the Partnership's operations are
subject to the administrative simplification provisions of HIPAA, and the
implementing regulations contained in 45 C.F.R. Parts 160, 162 and 164, are in
material compliance with those provisions and implementing regulations,
including in conducting any of the standard transactions set forth in 45 C.F.R.
Part 162; and (ii) are in compliance with all other applicable Information
Privacy or Security Laws (as hereinafter defined). 

                          (b)       
Copies of the compliance policies and/or procedures and privacy notices of the
Partnership relating to Information Privacy or Security Laws have been delivered
to Purchaser. 

                          (c)       
Partnership has entered into business associate agreements with all third
parties acting as a business associate as defined in 45 C.F.R. § 160.103 and to
Seller's knowledge, no business associate is in breach of its business associate
agreement with the Partnership or otherwise in violation of the Information
Privacy or Security Laws. To the Knowledge of Sellers, neither Sellers nor the
Partnership are under investigation by any Governmental Authority for a
violation of any Information Privacy or Security Laws, including the receipt of
any notices from the United States Department of Health and Human Services Office of Civil Rights, Federal Trade Commission, Department of
Justice, or state attorney general relating to any such violations. 

15 

                          (d)       
Copies of any written complaints alleging a violation of any Information Privacy
or Security Laws received by Partnership during the preceding twenty-four (24)
month period have been delivered to Purchaser. 

                          (e)       
Partnership has not had a Breach of Unsecured Protected Health Information, as
such terms are defined in 45 C.F.R. § 164.402. 

                          (f)      
For purposes of this Section 4.19: (i) "Information Privacy or
Security Laws" means HIPAA and regulations as set forth in Section
4.19 above and any other applicable Law concerning the privacy and/or
security of Personal Information, including state data breach notification laws,
state patient, medical record and health information privacy Laws, the Federal
Trade Commission Act and state consumer protection Laws; and (ii) "Personal
Information" means any information with respect to which there is a
reasonable basis to believe that the information can be used to identify an
individual, including "individually identifiable health information" as defined
in 45 C.F.R. 160.103, demographic information, and social security numbers and
such other personally identifiable information protected by applicable Legal
Requirement. 

                          (g)       
No Exclusion. Neither Sellers nor the Partnership nor any of their
respective officers, directors, agents, or employees, have been convicted of a
Medicare or other Federal Health Care Program (as defined in 42 U.S.C. §
1320a-7(b)(f)) related offense or convicted of, charged with or, to the
Knowledge of Sellers, investigated for, or engaged in conduct that would
constitute a violation of any Legal Requirements related to fraud, theft,
embezzlement, breach of fiduciary duty, kickbacks, bribes, other financial
misconduct or obstruction of an investigation. Neither Sellers, the Partnership,
nor any officer, director, agent, employee or independent contractor or medical
staff member of the Partnership (whether an individual or entity), has been
excluded from participating in any Government Program, subject to sanction
pursuant to 42 U.S.C. § 1320a-7a or § 1320a-8 or been convicted of a crime
described at 42 U.S.C. § 1320a-7b, nor, to Seller's knowledge, are any such
exclusions, sanctions or charges threatened or pending. 

            4.20    
 Full Disclosure. No representation or warranty by Sellers in this
Agreement and no statement contained in the schedules to this Agreement or any
certificate or other document furnished or to be furnished to Purchaser pursuant
to this Agreement contains any untrue statement of a material fact, or omits to
state a material fact necessary to make such statement or statements, in light
of the circumstances in which they are made, not misleading. 

ARTICLE V. 
REPRESENTATIONS AND WARRANTIES OF
PURCHASER 

            Purchaser,
jointly and severally, hereby represents and warrants to Sellers, as of the
Closing Date, as follows: 

            5.1       
Organization and Qualification of Purchaser. Purchaser is duly organized,
validly existing and in good standing under the Laws of British Columbia, Canada
and has the requisite power and authority to own, operate or lease the properties and
assets now owned, operated or leased by it and to carry on its business as
currently conducted by Purchaser. Purchaser is duly qualified to do business as
a foreign organization and is in good standing in each jurisdiction where the
character of its properties owned, operated or leased or the nature of its
activities makes such qualification necessary. 

16 

            5.2       
Capacity; Enforceability. Purchaser has all requisite power and authority
to execute and deliver this Agreement and to perform their respective
obligations hereunder. The execution and delivery by Purchaser of this Agreement
and the performance of its obligations hereunder have been duly and validly
authorized by Purchaser, and no other action on the part of Purchaser is
necessary. This Agreement has been duly and validly executed and delivered by
Purchaser and is, or will be, a legal, valid and binding obligation of
Purchaser, enforceable against Purchaser in accordance with its terms, except as
the enforceability may be limited by (a) applicable bankruptcy, insolvency,
moratorium, reorganization, fraudulent conveyance or similar Laws in effect
which affect the enforcement of creditors' rights generally; or (b) general
principles of equity. 

            5.3       
Consents and Approvals. Except as set forth on Schedule 5.3, no
consent, authorization or approval of, or filing or registration with, any
Governmental Authority or any other Person is necessary in connection with the
execution, delivery or performance by Purchaser of this Agreement or the
consummation by Purchaser of the transactions contemplated herein. Purchaser is
not a party to, subject to or bound by (or by which any of its properties or
assets may be bound) any Contract or order which does or would (a) conflict with
or be breached or violated or the obligations thereunder accelerated or
increased (whether or not with notice or lapse of time, or both) or give rise to
any payment obligation or loss of a benefit, or a right of termination,
cancellation, or modification, by the execution, delivery or performance by
Purchaser of this Agreement, or (b) prevent the carrying out of the transactions
contemplated herein. 

            5.4       
Brokers. No broker, finder, investment banker or other Person is entitled
to any brokerage fee, finders' fee or other commission in connection with the
transactions contemplated by this Agreement based upon arrangements made by
Purchaser. 

            5.5       
Full Disclosure. No representation or warranty by Purchaser in this
Agreement, no statement contained in the schedules to this Agreement or any
certificate or other document furnished or to be furnished to Purchaser pursuant
to this Agreement contains any untrue statement of a material fact, or omits to
state a material fact necessary to make such statement or statements, in light
of the circumstances in which they are made, not misleading. 

17 

ARTICLE VI. 
CONDITIONS PRECEDENT TO OBLIGATIONS OF
PURCHASER 

            The
obligations of Purchaser hereunder are, at the option of Purchaser, subject to
the satisfaction, on or prior to the Closing Date, of the following conditions
unless waived in writing by Purchaser: 

            6.1       
Compliance with Representations and Covenants. (a) The representations
and warranties of Sellers made in Sections 4.1, 4.2, 4.3, 4.4, and 4.20 and each
of the representations and warranties qualified as to materiality shall be true
and correct in all respects, and (b) those not so qualified shall be true and
correct in all material respects, as of the date hereof and as of the time of
the Closing as though made as of such time, except to the extent any such
representations and warranties expressly relates to an earlier date (in which
case, subject to part (a) of this Section 6.1, such representations and
warranties qualified as to materiality shall be true and correct, and those not
so qualified shall be true and correct in all material respects, on and as of
such earlier date). Sellers shall have duly performed, complied with and
satisfied all covenants, agreements and conditions required by this Agreement to
be performed, complied with or satisfied by it prior to the time of the Closing.

            6.2       
Financing. Purchaser shall be able to obtain financing of the Purchase
Price on commercially reasonable terms. 

            6.3       
Consents. The Parties shall have obtained all consents necessary for each
Party to consummate the transaction without resulting in a breach or default
under any agreement or Contract to which such Party is bound and each Party and
the Partnership shall have obtained the consent of any Governmental Authority
necessary for the Purchaser to operate the Partnership and continue the Business
after the Closing Date. 

            6.4       
Action/Proceeding. No Proceeding before a court or any other Governmental
Authority or body shall have been instituted or threatened by a third party to
restrain or prohibit the transactions herein contemplated. 

            6.5       
Closing Documents. Purchaser, in its sole discretion, shall have approved
of, and Sellers shall have executed and delivered to Purchaser, all of the
documents, agreements and certificates required to be executed or delivered by
Sellers pursuant to any term or provision of this Agreement. 

            6.6       
Encumbrances. At the Closing, Purchaser shall have received confirmation
in form and substance reasonably satisfactory to Purchaser that, immediately
following the Closing, any Indebtedness of Sellers, that is an encumbrance on
the Partnership's assets will either be fully repaid or refinanced and that
there will be no encumbrances applicable to the Partnership's assets or the
Hospital other than trade accounts payable and other Indebtedness that is in the
name of the Partnership. 

            6.7       
Material Assets and Material Asset Contracts. On or before April 21,
2015, Purchaser shall have received a copy of Schedule 4.7 in accordance with
the terms of Section 4.7, which presents, in a manner satisfactory to Purchaser
in its sole discretion, the material required to be so disclosed.

18 

ARTICLE VII. 
CONDITIONS PRECEDENT TO OBLIGATIONS
OF SELLERS 

            The
obligations of Sellers hereunder are, at the option of Sellers, subject to the
satisfaction, on or prior to the Closing Date, of the following conditions
unless waived in writing by Sellers: 

            7.1       
Compliance with Covenants. The representations and warranties of
Purchaser made in this Agreement qualified as to materiality shall be true and
correct, and those not so qualified shall be true and correct in all material
respects, as of the date hereof and as of the time of the Closing as though made
as of such time, except to the extent such representations and warranties
expressly relate to an earlier date (in which case such representations and
warranties qualified as to materiality shall be true and correct, and those not
so qualified shall be true and correct in all material respects, on and as of
such earlier date). Purchaser shall have duly performed, complied with and
satisfied all covenants, agreements and conditions required by this Agreement to
be performed, complied with or satisfied by them prior to the time of the
Closing. 

            7.2       
Consents. The Parties shall have obtained all consents necessary for each
Party to consummate the transaction without resulting in a breach or default
under any agreement or Contract to which such Party is bound and each Party and
the Partnership shall have obtained the consent of any Governmental Authority
necessary for the Purchaser to operate the Partnership and continue the Business
after the Closing Date. 

            7.3       
Action/Proceeding. No Proceeding before a court or any other Governmental
Authority shall have been instituted or threatened by a third party to restrain
or prohibit the transactions herein contemplated. 

            7.4       
Closing Documents. Sellers, in its sole discretion, shall have approved
of, and Purchaser shall have executed and delivered to Sellers all of the
documents, agreements and certificates required to be executed or delivered by
Purchaser pursuant to any term or provision of this Agreement. 

            7.5       
Real Estate Lease. The Partnership is a party to that certain Lease
Agreement between Medistar Hermann Dive Medical Center, Ltd., as Landlord, and
Victory Medical Center Houston, LP, as Tenant, dated June 9, 2011, as amended by
that certain First Amendment to Lease dated August 2011, that certain Second
Amendment to Lease Agreement dated July 18, 2012, that certain Third Amendment
to Lease Agreement dated January 1, 2014 and that certain Lease Amendment and
Extension dated November 10, 2014 (the "Real Estate Lease"). In
connection with this transaction, Purchaser will assume all warranties,
guarantees, liabilities and other obligations of Victory Hospital Properties,
LLC ("VPC Properties"), an Affiliate of Sellers, under that certain
Guaranty executed by VPC Properties on June 9, 2011. Further, Purchaser will
exercise all reasonable efforts to remove or replace Victory Hospital
Properties, LLC, as soon as reasonably practicable, VPC Properties from all
liabilities under such Guaranty and shall indemnify and hold harmless VPC
Properties, in accordance with ARTICLE IX below, from any default with respect
to the Real Estate Lease. For purposes of this Section 7.5, the Parties hereto
acknowledge and agree that VPC Properties is a third party
beneficiary with respect to the indemnification obligations of Purchase upon a
default as described herein.. 

19 

ARTICLE VIII. 
OTHER COVENANTS AND AGREEMENTS

      
     8.1       
Operations. From the date of this Agreement until the earlier of the
Closing Date or the termination of this Agreement, Sellers will cause the
Partnership to operate the Business in the ordinary course of business and
consistent with the past practices and Sellers will cause Partnership to use
commercially reasonable efforts to: (a) carry on the Business and its operations
in substantially the same manner as Partnership has heretofore and not make any
material change in personnel, operations, finance, accounting policies or real
or personal property of the Hospital, except in the ordinary course of business;
(b) perform all of Partnership's obligations under agreements relating to or
affecting the Partnership's assets or the Business; (c) keep in full force and
effect Partnership's present insurance policies or other comparable insurance;
(d) notify Purchaser immediately upon (i) the occurrence of any event, fact or
circumstance that is reasonably likely to result in the breach or inaccuracy of
any representation or warranty of Sellers contained in this Agreement, or (ii)
the discovery of any event, fact or circumstance from which a reasonable person
would conclude that any representation or warranty of Sellers contained in this
Agreement was inaccurate or incomplete when made; (e) maintain the Partnership's
assets and all parts thereof in as good working order and condition as at
present, ordinary wear and tear excepted; (f) maintain and preserve its business
organization with respect to the Business intact, retain its present employees
related to the Business and maintain its relationship with physicians,
suppliers, customers and others having business relations with the Business; and
(g) permit and allow reasonable access by Purchaser or an affiliate of Purchaser
to make offers of post-Closing employment to any of Sellers' personnel providing
services for the Business, which personnel shall be allowed to accept such
offers without penalty, competing offer or interference, and to establish
relationships with physicians and others having business relations with
Partnership 

            8.2       
Cooperation in Proceedings; Further Assurances. After Closing, VPC and GP
shall reasonably cooperate with the Purchaser in their efforts to continue and
maintain for the benefit of the Partnership those business relationships of
Partnership existing prior to Closing and relating to the Business of the
Partnership and the operation of the Hospital, including relationships with
lessors, employees, regulatory authorities, licensors, suppliers, lenders, and
others. VPC, GP and their respective officers, directors and managers, will
refer to the Partnership and/or Purchaser (as applicable) all inquiries relating
to the Partnership or the Hospital. Neither VPC, GP or their respective
officers, directors and managers shall take any action that would tend to
diminish the value of the Partnership after the Closing or that would interfere
with the Business of the Partnership or the operation of the Hospital. Following
the Closing, each of the parties hereto shall, and shall cause their respective
affiliates and representatives to, execute and deliver such additional
documents, instruments, conveyances and assurances and take such further actions
as may be reasonably required to carry out the provisions hereof and give effect
to the transactions contemplated by this Agreement. 

            8.3       
Confidentiality. Each Seller recognizes that each has had access to
certain confidential information and trade secrets relating to the Business that
are valuable, special and unique assets of Partnership, and each Seller agrees that it
shall not, and each shall cause its Affiliates not, to use or divulge to any
person, firm, corporation, association or other entity, for any purpose or
reason whatsoever, any confidential information or trade secrets relating to the
Business; provided, however, that the foregoing shall not apply to
information which: (a) is publicly available, generally known, or readily
ascertainable; (b) later becomes publicly available, generally known or readily
ascertainable through no fault of the applicable Seller; (c) is required to be
disclosed as a result of legal process; or (d) is disclosed to the applicable
Seller after the Closing by a third person not in violation of any obligation of
non-disclosure owed to Partnership or Purchaser. 

20 

            8.4       
Public Announcements. No Party shall make any public announcements in
respect of this Agreement or the transactions contemplated herein or otherwise
communicate with any news media without the prior written consent of the other
Party. The Parties are authorized to make any disclosures necessary to obtain
any consent required to be obtained by that Party in order to consummate the
transaction or as such disclosure as may be required for a Party to comply with
applicable Law. 

            8.5       
Further Assurances. From and after the Closing, the parties hereto shall
do such acts and execute such documents and instruments as may be reasonably
required to make effective the transactions contemplated hereby. 

            8.6       
Non-Solicitation/No Hire. For a period of one (1) year following the
Closing Date, each Seller shall not directly or indirectly through another
Person, (a) induce or attempt to induce any employee of Partnership to leave his
or her employment, or in any way interfere with the relationship between
Partnership and any such employee, or (b) call on, solicit or service any
customer, charterer, lessor, vendor, licensee, licensor or other business
relation of the Business in order to induce or attempt to induce such Person to
cease doing or decrease their business with Partnership and the Business, or in
any way interfere with the relationship between any such customer, charterer,
lessor, vendor, licensee, licensor or other business relation of the Business
and Partnership (including making any negative statements or communications
about the Business, Partnership or its Affiliates). 

            8.7       
Signage; Name Change. As soon as reasonably practicable after the
Closing, Purchaser shall cause the Partnership to change its name to such name
as Purchaser shall desire that does not include the word "Victory". Within
thirty (30) days Purchaser shall have removed all signage on or about the acute
care hospital containing the word "Victory."

             8.8        Audited Financials;
  Consents. VPC shall cause to be completed the audited balance sheet and the
  related audited statements of income and cash flows for the year ended December
  31, 2014 (the “2014 Financials”), which VPC shall deliver to Purchaser,
  as soon as reasonably practicable after the 2014 Financials’ completion. In the
  event that VPC incurs additional expenses in auditor fees after April 17, 2015,
  Purchaser shall pay directly or reimburse VPC for the amount of such fees within
  30 days of receiving an itemized bill. VPC shall request in writing the consent
  of each accounting firm that conducted an audit (partial or completed) of the
  Partnership’s financial circumstances for the years ended December 31, 2014,
  December 31, 2013 and December 31, 2012 to use such firm’s audited financial
  statements in any public filings of the Purchaser’s corporate parent, Nobilis
  Health Corp.

21 

            8.9       
UMB Payoff. On or before the day that is thirty (30) days after the
Closing Date or the first such Business Day thereafter, Purchaser or its
assignee shall loan to the Partnership in an original principal amount equal to
the aggregate outstanding balances of those certain Promissory Notes, each dated
January 23, 2014 and executed by the Partnership in favor of UMB Bank n.a., in
the original principal amounts of Nine Million and No/100 Dollars
($9,000,000.00) and One Million Five Hundred Thousand and No/100 Dollars
($1,500,000.00), respectively (collectively, the "UMB Notes"). The loan
shall be evidenced by a promissory note from the Partnership in favor of
Purchaser (the "Partnership Promissory Note") in substantially the same
form as the promissory note attached to this Agreement as Exhibit A. The
proceeds of the loan will be paid directly to the holder of the UMB Notes, in
full satisfaction thereof. 

ARTICLE IX. 
SURVIVAL; INDEMNIFICATION 

            9.1       
Survival. 

                          (a)       
The representations and warranties of Sellers contained in this Agreement shall
survive for a period of twenty-four (24) months following the Closing Date,
except for representations and warranties contained in Sections 4.1, 4.2, 4.3,
and 4.4, which will continue in full force and effect in perpetuity;
provided, however, such survival period shall not apply to any
breach or nonfulfillment of any covenants or agreements made by Partnership
herein or in any document executed in connection herewith, including, but not
limited to, the failure to abide by the non-competition and confidentiality
provisions contained herein, and shall further not apply claims involving fraud,
willful misconduct or intentional misrepresentation on the part of Partnership.

                          (b)       
The representations and warranties of Purchaser contained in Article V shall
survive for a period of twenty-four (24) months from the Closing Date, except
for representations and warranties contained in Sections 5.1, 5.2 and 5.3, which
will continue in full force and effect in perpetuity; provided however, such
survival period shall not apply to any breach or nonfulfillment of any covenants
or agreements made by Purchaser herein or in any document executed in connection
herewith. 

            9.2       
Indemnification by Sellers. 

                          (a)       
Subject to the provisions and limitations of this Article, from and after the
Closing Date, each Seller, jointly-and-severally, shall indemnify and hold
harmless Purchaser and its Affiliates (the "Purchaser Indemnified
Parties") from and against any and all Taxes, claims, liabilities, damages,
losses, demands, obligations, deficiencies, costs, and expenses of any nature
whatsoever, including, without limitation, reasonable attorneys' fees,
accountants' fees, or diminution in value, and all costs of investigation, and
other expenses of defending any actions or claims, amounts of judgment and
amounts paid in settlement, whether or not involving a third party claim,
together with interest thereon at the rate provided by Law, compounded annually
from the date incurred until paid (collectively referred to as the
"Damages"), suffered by such Purchaser Indemnified Parties resulting from
or arising out of (i) any breach of any of the representations or warranties
made by Sellers in this Agreement or in any document executed in connection
herewith, (ii) any breach or nonfulfillment of any covenants or agreements made
by Sellers in this Agreement or in any document executed in
connection herewith, or (iii) any event arising from the operation and ownership
of, or conditions occurring with respect to, Partnership or the Business
(including but not limited to the Hospital) before 11:59 p.m. on the Closing
Date (each claim made by the Purchaser Indemnified Parties pursuant to this
Section 9.2(a) shall be a "Purchaser Claim"). 

22 

                          (b)       
The Purchaser Indemnified Parties shall not be entitled to assert any Purchaser
Claim for indemnification pursuant to this Section 9.2 after the dates provided
in Section 9.1; provided, however, that if on or prior to such
date a Notice of Claim (as defined below) shall have been given pursuant to
Section 9.4 hereof for such indemnification, the Purchaser Indemnified Parties
shall continue to have the right to be indemnified with respect to such
Purchaser Claim until such claim for indemnification has been satisfied or
otherwise resolved as provided in this Article. 

                          (c)       
All Purchaser Claims shall be net of any insurance proceeds actually received as
a result of the matter for which indemnification is claimed. 

                          (d)       
Sellers shall have no recourse against Partnership in the event the Sellers are
required to indemnify the Purchaser Indemnified Parties pursuant to this
Agreement. 

            9.3       
Indemnification by Purchaser. 

                          (a)       
Subject to the provisions of this Article, from and after the Closing Date,
Purchaser shall indemnify and hold harmless Sellers and their Affiliates (the
"Seller Indemnified Parties") from and against any and all Damages
(as defined in Section 9.2(a) herein) suffered by such Seller Indemnified
Parties resulting from or arising out of (i) any breach of any of the
representations or warranties made by the Purchaser in this Agreement or in any
document executed in connection herewith, (ii) any breach or nonfulfillment of
any covenants or agreements made by Purchaser herein or any document executed in
connection herewith, notwithstanding when any such breach or nonfulfillment may
occur, (iii) the operation of the Business (including without limitation the
Hospital) from and after 11:59 p.m. on the Closing Date; and (iv) any default
with respect to the Equipment Leases assumed by the Purchaser as described in
Section 3.1(d) above. 

                          (b)       
None of the Seller Indemnified Parties shall be entitled to assert any claim for
indemnification pursuant to this Section 9.3 after the dates provided in Section
9.1; provided, however, that if on or prior to such date a Notice
of Claim shall have been given pursuant to Section 9.4 hereof for such
indemnification, the Seller Indemnified Parties shall continue to have the right
to be indemnified with respect to such indemnification claim until such claim
for indemnification has been satisfied or otherwise resolved as provided in this
Article. 

                          (c)       
All claims for indemnification by Seller Indemnified Parties shall be net of any
insurance proceeds actually received as a result of the matter for which
indemnification is claimed. 

           
9.4        Indemnification Procedures.

23 

                          (a)       
Upon obtaining knowledge of any claim or demand which has given rise to a claim
for indemnification under Section 9.2 or Section 9.3, the Purchaser Indemnified
Parties or the Seller Indemnified Parties (each, an "Indemnified Party")
shall give written notice ("Notice of Claim") of such claim or demand to
the Seller Indemnified Parties or Purchaser (each, an "Indemnifying
Party"). In each case, such Notice of Claim shall specify in reasonable
detail such information as the Indemnified Parties may have with respect to such
indemnification claim (including copies of any summons, complaint or other
pleading which may have been served on such party and any written claim, demand,
invoice, billing or other document evidencing or asserting the same);
provided, however, that, subject to the limitations set forth in
Sections 9.1, 9.2 or 9.3, respectively, no failure or delay by the party giving
the Notice of Claim shall reduce or otherwise affect the obligation of the
Indemnifying Party unless and to the extent the Indemnifying Party is thereby
prejudiced. 

                          (b)       
Within thirty (30) Business Days of receiving a Notice of Claim, the
Indemnifying Party may object to such indemnification claim, stating in
reasonable detail the bases for such objection. Any objection to a Notice of
Claim must be signed by one or more representatives of the Indemnifying Party or
its counsel and shall set forth in reasonable detail the items as to which
disagreement exists (the "Disputed Matters"). If an objection is
delivered, the Indemnified Party and the Indemnifying Party shall negotiate in
good faith to resolve in writing any Disputed Matters. If they are unable to
reach an agreement with respect to the Disputed Matters within a period of
thirty (30) Business Days after the receipt of an objection, then the parties
shall be free to pursue litigation with respect to any such Disputed Matters as
to which written agreement has not been reached shall be resolved in a manner
consistent with ARTICLE X. 

                          (c)       
If any lawsuit or other action is filed or instituted against any of the
Indemnified Parties with respect to a matter subject to indemnity hereunder (a
"Third Party Claim"), notice thereof (a "Third Party
Notice") shall be given to the Indemnifying Party as promptly as practicable
(and in any event within fifteen (15) calendar days after the service of the
citation or summons). Subject to the limitations set forth in Sections 9.1, 9.2
or 9.3, respectively, the failure of the Indemnified Parties to give timely
notice hereunder shall not affect rights to indemnification hereunder, except to
the extent the Indemnifying Party has actually been prejudiced as a result.
After receipt of a Third Party Notice, the Indemnifying Party shall have the
right to conduct the defense of the claim through counsel selected by the
Indemnifying Party and approved by the Indemnified Party (which approval shall
not be unreasonably withheld), and the assertion of such right shall constitute
an acknowledgment by the Indemnifying Party that such claim is an indemnifiable
claim for which the Indemnifying Party is responsible under Sections 9.2 or 9.3
above. The Indemnified Party may retain separate co-counsel at its sole cost and
expense and participate in the defense of the Third Party Claim. If the
Indemnifying Party does not assume and diligently conduct such defense, the
Indemnifying Party shall be liable for all costs and expenses incurred by the
Indemnified Party in defending the claim, including reasonable fees and
disbursements of counsel. Neither the Indemnifying Party nor the Indemnified
Party will consent to the entry of any judgment or enter into any settlement
with respect to such Third Party Claim without the prior written consent of the
other party (i.e., the Indemnified Party or the Indemnifying Party, as
applicable), which consent will not be unreasonably withheld, delayed or
conditioned. In the event, after having first provided the Indemnifying Party an
opportunity to fulfill the obligations of the Indemnifying Party hereunder, the Indemnified Party then brings an action against the
Indemnifying Party upon any claim for indemnification under Sections 9.2 or 9.3
above, the Indemnifying Party shall be liable to the Indemnified Party for the
Indemnified Party's reasonable fees and disbursements of counsel in connection
therewith if the Indemnified Party prevails in the action. The parties shall
also cooperate with each other in any notifications to insurers.

24 

                          (d)       
If the indemnification claim is made pursuant to Section 9.2, the total amount
of such matured claims shall be paid in accordance with Section 9.2; likewise,
if the indemnification claim is made pursuant to Section 9.3, the total amount
of such matured claims shall be paid in accordance with Section 9.3. 

            9.5       
Limitations on Indemnification of Sellers. Except as set forth in the
last and next to last sentence of this Section 9.5, the Sellers will have no
liability for money Damages under Section 9.2 unless and until the aggregate
Damages claimed under Section 9.2(a) exceed $50,000 (individual claims of less
than $5,000 that are not reasonably related to other claims shall not be
included in the calculation of such $50,000); provided, however,
that if the aggregate Damages claimed under Section 9.2(a) exceed $50,000, then
Sellers' liability will relate back to and include the first dollar of aggregate
Damages so claimed, in which case Sellers' liability will relate back to and
include the first dollar of aggregate Damages so claimed; provided,
further, that Sellers' aggregate liability for money Damages will not
exceed the sum of the Cash Consideration and the assumed Intercompany Debt.

            9.6       
Exclusive Remedy. The rights of the Indemnified Parties under this
ARTICLE IX shall be the exclusive remedy of such Indemnified Parties with
respect to claims resulting from any breach by the Indemnifying Parties of any
representation, warranty, covenant or agreement contained in this Agreement;
provided, however, that this Section 9.6 is not intended in any
way to limit or restrict the right of any party to separately seek equitable
remedies, including injunctive relief or to pursue a claim for fraud or other
non-waivable rights of action. 

            9.7       
Tax Treatment of Indemnity Payments. All amounts paid with respect to
indemnity claims under this Agreement shall be treated by the parties hereto for
all Tax purposes as adjustments to the Purchase Price, unless otherwise required
by Law. 

ARTICLE X. 
DISPUTED MATTERS 

            10.1    
 Attorneys' Fees With Respect to Litigation. If any Seller, on the
one hand, or Purchaser, on the other hand, initiates any legal action or lawsuit
against the other, involving this Agreement or any agreement executed pursuant
hereto, the prevailing party in such action or suit shall be entitled to receive
reimbursement from the other party for all reasonable attorneys' fees, experts'
fees, and other costs and expenses incurred by the prevailing party in respect
of that Proceeding, including any and all appeals thereof, and such
reimbursement shall be included in judgment or final order issued in such
Proceeding. 

            10.2    
 Governing Law; Jurisdiction and Venue. This Agreement shall be
governed by and construed in accordance with the Laws of the State of Texas,
excluding its conflict of laws provisions. Each party hereto hereby irrevocably
submits to the exclusive jurisdiction of the United States District Court located in Harris County, Texas,
for the purposes of any action arising out of this Agreement or the subject
matter hereof brought by any party under this Agreement. To the extent permitted
by applicable Law, each party hereby waives and agrees not to assert, by way of
motion, as a defense or otherwise, in any action under this Agreement, any claim
(a) that it is not personally subject to the jurisdiction of the above-named
courts, (b) that such action is brought in an inconvenient forum, (c) that it is
immune from any legal process with respect to itself or its property, (d) that
the venue of the Proceeding is improper, or (e) that this Agreement or the
subject matter hereof may not be enforced in or by such courts. 

25 

ARTICLE XI. 
MISCELLANEOUS 

            11.1     
Waiver. At any time prior to the Closing Date, any party hereto may (a)
extend the time for the performance of any of the obligations or other acts of
the other parties hereto, (b) waive any inaccuracies in the representations and
warranties of the other parties contained herein or in any document delivered
pursuant hereto, and (c) waive compliance by the other parties with any of the
agreements or conditions contained herein. Any such waiver shall be valid only
if set forth in an instrument in writing signed by the party or parties to be
bound thereby, but such extension, waiver or failure to insist on strict
compliance with an obligation, covenant, agreement or condition shall not
operate as a waiver of, or estoppel with respect to, any subsequent or other
failure. 

            11.2     
Notices. Any notices or other communications required or permitted under,
or otherwise in connection with this Agreement, shall be in writing and shall be
deemed to have been duly given when delivered in person or upon confirmation of
receipt when transmitted by facsimile transmission (but only if followed by
transmittal by national overnight courier or hand delivery on the next Business
Day or by international courier for delivery within the next three (3) Business
Days) or on receipt after dispatch by registered or certified mail, postage
prepaid, addressed, or on the next Business Day if transmitted by national
overnight courier or within the next three (3) Business Days if transmitted by
international courier, in each case as follows: 

	 	If to Purchaser, to: 	______________________________________________
	 	 	______________________________________________
	 	 	 ______________________________________________
	 	 	Attention:
      ______________________________________
	 	 	Facsimile No.:
      ___________________________________
	 	 	 
	 	 	 
	 	With a copy to: 	
	 	 	______________________________________________
	 	 	______________________________________________
	 	 	______________________________________________
	 	 	Attention:
      ______________________________________
	 	 	Facsimile No.:
      ___________________________________
	 	 	 
	 	 	 
	 	If to Sellers, to: 	______________________________________________
	 	 	______________________________________________
	 		______________________________________________
    

26 

	 	 	Attention:
      ______________________________________
	 	 	Facsimile No.:
      ___________________________________
	 	 	  
	 	With a copy to: 	______________________________________________
	 	 	______________________________________________
	 	 	______________________________________________ 

	 	 	Attention:
      ______________________________________
	 	 	Facsimile No.:
      ___________________________________

            11.3    
 Assignment. No party hereto shall assign this Agreement or any part
hereof without the prior written consent of the other party; provided,
however, Purchaser may assign its rights hereunder to any Affiliate.
Except as otherwise provided herein, this Agreement shall be binding upon and
inure to the benefit of the parties hereto and their respective permitted
successors and assigns. 

            11.4    
 Rights of Third Parties. Nothing expressed or implied in this
Agreement is intended or shall be construed to confer upon or give any Person,
other than the parties hereto, any right or remedies under or by reason of this
Agreement. 

            11.5    
 Reliance. Each of the parties to this Agreement shall be deemed to
have relied upon the accuracy of the written representations and warranties made
to it in or pursuant to this Agreement, notwithstanding any investigations
conducted by or on its behalf or notice, knowledge or belief to the contrary.

            11.6    
 Expenses. Each party hereto shall bear its own expenses incurred in
connection with this Agreement and the transactions herein contemplated whether
or not such transactions shall be consummated, including, without limitation,
fees of its legal counsel, financial advisers and accountants; provided,
however, prior to Closing the Partnership shall pay all of the costs and
expenses of the Sellers and Partnership incurred in connection with or related
to the authorization, preparation and execution of this Agreement and the
closing of the transactions contemplated herein. 

            11.7    
 Captions; Counterparts. The captions in this Agreement are for
convenience only and shall not be considered a part of or affect the
construction or interpretation of any provision of this Agreement. This
Agreement may be executed in two or more counterparts (including by means of
facsimile), each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. 

            11.8    
 Entire Agreement. This Agreement (together with the Exhibits and
the Schedules to this Agreement) constitute the entire agreement among the
parties and supersede any other agreements, whether written or oral, that may
have been made or entered into by or among any of the parties hereto or any of
their respective Affiliates relating to the transactions contemplated hereby and
thereby. No representations, warranties, covenants, understandings, agreements,
oral or otherwise, relating to the transactions contemplated by this Agreement
exist between the parties except as expressly set forth in this Agreement. 

            11.9    
 Severability. If any provision of this Agreement (or any portion
thereof) or the application of any such provision (or any portion thereof) to
any person of circumstance shall be held invalid, illegal or unenforceable in any respect by a
court of competent jurisdiction, the parties hereto request that the court
reform such provision in a manner sufficient to cause such provision to be
enforceable. 

27 

            11.10   
Amendments. This Agreement may be amended only by a written instrument
signed by both parties. 

[Signature Pages Next Page] 

28 

      
     IN WITNESS WHEREOF, this Partnership
Interest Purchase Agreement has been duly executed and delivered as of the date
first above written. 

	 	PURCHASER: 
	 	 
	 	 
	 	 
	 	Nobilis Health Holdings Corp. 
	 	a British Columbia corporation 
	 	 
	 	 
	 	By: /s/ Harry
      Fleming                                                                                
	 	Name: Harry Fleming 
	 	Title: Authorized Person 
	 	 
	 	 
	 	SELLERS: 
	 	 
	 	 
	 	Victory Parent Company, LLC 
	 	a Texas limited liability company 
	 	 
	 	 
	 	By: /s/ Robert N. Helms,
      Jr.                                                                      
      
	 	Name: Robert N. Helms, Jr. 
	 	Title: Manager 
	 	 
	 	 
	 	Victory Medical Center Houston GP, LLC
    
	 	a Texas limited liability company 
	 	 
	 	 
	 	By: /s/ Robert N. Helms,
      Jr.                                                                      
      
	 	Name: Robert N. Helms, Jr. 
	 	Title: Manager 

Execution Version 

  Partnership Interest Purchase Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]